Givaudan SA
Givaudan SA (GVDBF) Financial Performance & Income Statement Overview
Analyze Givaudan SA (GVDBF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Givaudan SA (GVDBF) Income Statement & Financial Overview
Explore comprehensive income reports for Givaudan SA GVDBF, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $3.67B | $3.74B | $3.38B | $1.69B |
| Cost of Revenue | $2.12B | $2.09B | $2.05B | $991.00M |
| Gross Profit | $1.55B | $1.65B | $1.33B | $699.00M |
| Gross Profit Ratio | $0.42 | $0.44 | $0.39 | $0.41 |
| R&D Expenses | $269.00M | $280.00M | $242.00M | $128.50M |
| SG&A Expenses | $586.00M | $589.00M | $515.00M | $278.50M |
| Operating Expenses | $888.00M | $917.00M | $796.00M | $437.00M |
| Total Costs & Expenses | -$3.009B | $3.008B | $2.85B | $1.43B |
| Interest Income | $9.00M | $17.00M | $5.00M | $25.50M |
| Interest Expense | $58.00M | $56.00M | $56.00M | $0.00 |
| Depreciation & Amortization | $186.00M | $173.00M | $179.00M | $36.50M |
| EBITDA | $853.00M | $902.00M | $714.00M | $302.50M |
| EBITDA Ratio | $0.23 | $0.24 | $0.21 | $0.18 |
| Operating Income | $666.00M | $729.00M | $535.00M | $266.00M |
| Operating Income Ratio | $0.18 | $0.20 | $0.16 | $0.16 |
| Other Income/Expenses (Net) | -$57.00M | -$29.00M | -$298.50M | -$29.50M |
| Income Before Tax | $609.00M | $700.00M | $471.00M | $236.50M |
| Income Before Tax Ratio | $0.17 | $0.19 | $0.14 | $0.14 |
| Income Tax Expense | $111.00M | $112.00M | $29.00M | $14.50M |
| Net Income | $502.00M | $588.00M | $444.00M | $222.00M |
| Net Income Ratio | $0.14 | $0.16 | $0.13 | $0.13 |
| EPS | $54.41 | $63.76 | $48.12 | $23.97 |
| Diluted EPS | $54.13 | $63.50 | $47.95 | $23.97 |
| Weighted Avg Shares Outstanding | $9.23M | $9.22M | $9.23M | $9.26M |
| Weighted Avg Shares Outstanding (Diluted) | $9.27M | $9.26M | $9.26M | $9.26M |
Over the past four quarters, Givaudan SA demonstrated steady revenue growth, increasing from $1.69B in Q3 2023 to $3.67B in Q4 2024. Operating income reached $666.00M in Q4 2024, maintaining a consistent 18% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $853.00M, reflecting operational efficiency. Net income dropped to $502.00M, with EPS at $54.41. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan